- Home
- PRE vs NSPR Comparison
PRE vs NSPR Comparison
Compare PRE & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRE
- NSPR
- Stock Information
- Founded
- PRE 2014
- NSPR 2005
- Country
- PRE Hong Kong
- NSPR Israel
- Employees
- PRE N/A
- NSPR N/A
- Industry
- PRE Biotechnology: Laboratory Analytical Instruments
- NSPR Medical/Dental Instruments
- Sector
- PRE Industrials
- NSPR Health Care
- Exchange
- PRE Nasdaq
- NSPR Nasdaq
- Market Cap
- PRE 72.6M
- NSPR 63.0M
- IPO Year
- PRE N/A
- NSPR N/A
- Fundamental
- Price
- PRE $5.53
- NSPR $2.93
- Analyst Decision
- PRE Buy
- NSPR Strong Buy
- Analyst Count
- PRE 1
- NSPR 2
- Target Price
- PRE $9.00
- NSPR $4.75
- AVG Volume (30 Days)
- PRE 13.0K
- NSPR 78.6K
- Earning Date
- PRE 11-27-2024
- NSPR 11-12-2024
- Dividend Yield
- PRE N/A
- NSPR N/A
- EPS Growth
- PRE N/A
- NSPR N/A
- EPS
- PRE N/A
- NSPR N/A
- Revenue
- PRE $25,561,362.00
- NSPR $6,821,000.00
- Revenue This Year
- PRE $64.44
- NSPR $13.31
- Revenue Next Year
- PRE $154.24
- NSPR $52.91
- P/E Ratio
- PRE N/A
- NSPR N/A
- Revenue Growth
- PRE N/A
- NSPR 24.70
- 52 Week Low
- PRE $2.85
- NSPR $1.81
- 52 Week High
- PRE $7.84
- NSPR $3.42
- Technical
- Relative Strength Index (RSI)
- PRE 66.84
- NSPR 52.69
- Support Level
- PRE $5.06
- NSPR $2.78
- Resistance Level
- PRE $5.35
- NSPR $3.15
- Average True Range (ATR)
- PRE 0.20
- NSPR 0.22
- MACD
- PRE 0.09
- NSPR -0.03
- Stochastic Oscillator
- PRE 94.44
- NSPR 47.58
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.